A Multi-center Study on Artificial Intelligence-Based Quantitative Evaluation of Echocardiography
NCT ID: NCT07133516
Last Updated: 2025-08-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
1600 participants
OBSERVATIONAL
2025-07-22
2026-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
1. Compare the automatic measurement results of AI with the manual measurement data from physicians of different levels, and analyze the measurement deviation and consistency of AI in key parameters such as intracardiac diameter, volume, and function.
2. Investigate whether AI-assisted measurement can significantly reduce echocardiogram analysis time and optimize clinical workflows. Through multi-center data validation, establish a standardized reference system for AI ultrasound measurement, promote the promotion and application of AI technology in medical institutions at all levels, and reduce diagnostic differences between different hospitals and physicians.
3. Exploring the application of AI in special cases: Assessing the measurement stability of AI algorithms in complex cases (such as cardiomyopathy, valvular disease, coronary heart disease, etc.), and optimizing AI models to meet broader clinical needs.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Normal Values of Cardiac Measurements by Echocardiography in Chinese Based on Artificial Intelligence
NCT06234241
AI-Enabled Diagnosis and Prognosis of Hypertrophic Cardiomyopathy
NCT07263204
A Multicenter Study on the Normal Reference Range and Clinical Significance of the Right Atrioventricular Coupling Index Assessed by Artificial Intelligence-Based Three-Dimensional Echocardiography
NCT07292896
Feasibility of AI-based Heart Function Prediction Model Using CXR
NCT04996381
A Multicenter Study of Artificial Intelligence Model for Fetal Congenital Heart Disease
NCT06796127
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
To overcome these bottlenecks, this project collaborates with multiple medical institutions to conduct clinical research, systematically evaluating the measurement differences between AI algorithms and physicians of different levels, and assessing the accuracy and stability of AI algorithms. The research will focus on verifying the value of AI technology in improving diagnostic consistency, optimizing workflows, and exploring its potential applications in complex cardiovascular diseases. By establishing a standardized evaluation system, this project aims to promote the standardized application of AI ultrasound technology, ultimately achieving the goal of improving diagnosis and treatment efficiency, promoting the sinking of high-quality medical resources, and helping to improve the overall level of cardiovascular disease prevention and treatment.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
AI group
The cardiac chamber size and functional parameters of all 1600 subjects were measured by AI
No interventions assigned to this group
Senior physician group
The cardiac chamber size and functional parameters of all 1600 subjects were measured by senior physicians at the PI unit
No interventions assigned to this group
Intermediate physician group
The cardiac chamber size and functional parameters of all 1600 subjects were measured by intermediate physicians at each sub center
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Types of diseases (8 in total, 200 cases each):
1. Normal heart
2. Coronary heart disease (with segmental thinning and abnormal movement)
3. Valve disease (valve stenosis or reflux)
4. Hypertensive heart disease
5. Atrial fibrillation
6. Heart failure
7. Dilated cardiomyopathy
8. Hypertrophic cardiomyopathy
Exclusion Criteria
2. Patients with poor image quality
18 Years
80 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
First Hospital of China Medical University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Chunyan Ma
Chief of Cardiovascular Ultrasound
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Huainan First People's Hospital
Huainan, Anhui, China
Union Hospital Affiliated to Fujian Medical University
Fuzhou, Fujian, China
Meizhou People's Hospital
Meizhou, Guangdong, China
Shantou Central Hospital
Shantou, Guangdong, China
Shenzhen Hospital of Fuwai Hospital
Shenzhen, Guangdong, China
Shenzhen People's Hospital
Shenzhen, Guangdong, China
Affiliated Hospital of Youjiang Medical University for Nationalities
Baise City, Guangxi, China
Guilin Hospital of Traditional Chinese Medicine
Guilin, Guangxi, China
The Fourth Affiliated Hospital of Guangxi Medical University / Liuzhou Workers' Hospital
Liuzhou, Guangxi, China
Yulin First People's Hospital
Yulin, Guangxi, China
The Second Affiliated Hospital of Zunyi Medical University
Zunyi, Guizhou, China
Haikou People's Hospital
Haikou, Hainan, China
The Second Affiliated Hospital of Hebei Medical University
Shijiazhuang, Hebei, China
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Wuhan, Hubei, China
Loudi First People's Hospital
Loudi, Hunan, China
Hunan Province Directly Affiliated TCM Hospital
Zhuzhou, Hunan, China
Baotou No.4 Hospital
Baotou, Inner Mongolia, China
Shangrao Central Hospital
Shangrao, Jiangxi, China
Shangrao People's Hospital
Shangrao, Jiangxi, China
Ansteel Group General Hospital
Anshan, Liaoning, China
Chaoyang Central Hospital
Chaoyang, Liaoning, China
Fushun Central Hospital
Fushun, Liaoning, China
Shengjing Hospital of China Medical University
Shenyang, Liaoning, China
The First Hospital of China Medical University
Shenyang, Liaoning, China
Qinghai Provincial Hospital of Cardiovascular and Cerebrovascular Diseases
Xining, Qinghai, China
The Central Hospital Affiliated to Shandong First Medical University
Tai’an, Shandong, China
Linfen People's Hospital
Linfen, Shanxi, China
The Second Affiliated Hospital of Xi'an Jiaotong University
Xi’an, Shanxi, China
Jiangyou 903 Hospital
Jiangyou, Sichuan, China
Bishan Hospital Affiliated to Chongqing Medical University
Chongqing, , China
Bishan Hospital Affiliated to Chongqing University of Chinese Medicine (Chongqing Bishan District Hospital of Traditional Chinese Medicine)
Chongqing, , China
Chongqing Hospital of Traditional Chinese Medicine
Chongqing, , China
Chongqing People's Hospital
Chongqing, , China
Fuling Hospital Affiliated to Chongqing University
Chongqing, , China
The First Affiliated Hospital of Army Medical University
Chongqing, , China
The Second Affiliated Hospital of Chongqing Medical University
Chongqing, , China
Shanghai Changzheng Hospital
Shanghai, , China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Chunyan Ma the First Hospital of China Medical Univeristy, Ph.D
Role: CONTACT
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Binghui Duan
Role: primary
Jinguo Li
Role: primary
Youhong Zhang
Role: primary
Liangyu Wang
Role: primary
Yong Jiang
Role: primary
Yingying Liu
Role: primary
Chengcai Chen
Role: primary
Mingyue Wu
Role: primary
Bo Hu
Role: primary
Hongxia Yin
Role: primary
Wei Zeng
Role: primary
Zelai Mo
Role: primary
Hongning Yin
Role: primary
Mingxing Xie
Role: primary
Weiqun Yin
Role: primary
Yibo Zhang
Role: primary
Yan Jing
Role: primary
Dongdong Huang
Role: primary
Shunping Qiu
Role: primary
Ying Liu
Role: primary
Hong Zhou
Role: primary
Wei Wang
Role: primary
Weidong Ren
Role: primary
Chunyan Ma
Role: primary
Renbo Jin
Role: primary
Lihua Jin
Role: primary
Liyan Guo
Role: primary
Qi Zhou
Role: primary
Juanjuan Wu
Role: primary
Min Lu
Role: primary
Xiaoli Zhang
Role: primary
Yang Yang
Role: primary
Shigen Zhong
Role: primary
Zhirong He
Role: primary
Yanli Guo
Role: primary
Haitao Ran
Role: primary
Chun Liang
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MAIQUEE STUDY
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.